|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Memorial Sloan-Kettering Cancer Center |
|---|---|
| Collaborator: |
National Cancer Institute (NCI) |
| Information provided by: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00503646 |
Purpose
RATIONALE: Participating in a therapy program may enhance communication and intimacy between men with prostate cancer and their partners.
PURPOSE: This randomized clinical trial is studying how well therapy enhances communication and intimacy for men with early stage prostate cancer and for their partners.
| Condition | Intervention |
|---|---|
|
Prostate Cancer Psychosocial Effects of Cancer and Its Treatment Sexual Dysfunction and Infertility Sexuality |
Other: communication intervention Other: counseling intervention Other: questionnaire administration Procedure: psychosocial assessment and care |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized |
| Official Title: | Communication and Intimacy-Enhancing Intervention for Men Diagnosed With Early Stage Prostate Cancer and Their Partners: A Pilot and Feasibility Trial |
| Estimated Enrollment: | 100 |
| Study Start Date: | May 2007 |
| Estimated Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |
OBJECTIVES:
Primary
OUTLINE: This is a multicenter study. Patients and their partners are randomized to 1 of 2 intervention arms.
Physical impairment, psychological adjustment, relationship closeness, relationship communication, sexual function and satisfaction, male self-esteem, relationship satisfaction, intervention evaluation, and erectile dysfunction treatment utilization, and referral are assessed at 1 week post-intervention or at 6-8 weeks post baseline and then at 3 months (for patients and their partners in arm I) and at 8 weeks post-baseline and then at 3 months (for patients and their partners in arm II).
PROJECTED ACCRUAL: A total of 50 patients and 50 partners will be accrued for this study.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
DISEASE CHARACTERISTICS:
Patient has a primary diagnosis of localized (early stage) prostate cancer
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Contacts and Locations| United States, New York | |
| Memorial Sloan-Kettering Cancer Center | Recruiting |
| New York, New York, United States, 10022 | |
| Contact: Christian J. Nelson, PhD 646-888-0030 nelsonc@mskcc.org | |
| United States, Pennsylvania | |
| Fox Chase Cancer Center - Philadelphia | Recruiting |
| Philadelphia, Pennsylvania, United States, 19111-2497 | |
| Contact: Clinical Trials Office - Fox Chase Cancer Center - Philadelphi 215-728-4790 | |
| Principal Investigator: | David W. Kissane, MD | Memorial Sloan-Kettering Cancer Center |
| Principal Investigator: | Christian J. Nelson, PhD | Memorial Sloan-Kettering Cancer Center |
More Information
| ClinicalTrials.gov Identifier: | NCT00503646 History of Changes |
| Other Study ID Numbers: | CDR0000557017, MSKCC-07069 |
| Study First Received: | July 17, 2007 |
| Last Updated: | February 18, 2011 |
| Health Authority: | Unspecified |
|
psychosocial effects of cancer and its treatment sexual dysfunction and infertility sexuality and reproductive issues |
stage IIB prostate cancer stage IIA prostate cancer stage I prostate cancer |
|
Infertility Prostatic Neoplasms Genital Diseases, Male Genital Diseases, Female Genital Neoplasms, Male |
Urogenital Neoplasms Neoplasms by Site Neoplasms Prostatic Diseases |